Plain-English translation of NCT07015749 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new medication called to see if it is safe and helps people with asthma. The medication is given as an injection under the skin, and researchers will carefully watch for any side effects and measure how well it works in people whose asthma is not fully controlled by their current inhalers.
Some people with asthma continue to have symptoms even when taking inhaled medications, especially those with high levels of a type of immune cell called eosinophils. This trial exists to see whether this new treatment might help these patients breathe easier and have fewer asthma attacks.
You likely qualify if…
You likely don't qualify if…
You would visit the study clinic for an initial screening (about 4 weeks), then receive injections of either the new medication or a placebo under your skin over a 12-week treatment period. After each injection, you would stay at the clinic for 3 hours so doctors can check that you're doing well. The study would continue with follow-up visits for 8 more weeks after your last injection to make sure everything remains safe. Throughout the study, doctors will test your breathing, measure your eosinophil levels, and ask about your asthma symptoms.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China